Example: stock market
Package leaflet: Information for the user Diflucan 150 mg ...
Page 1 of 9 Package leaflet: Information for the user Diflucan® 150 mg hard capsules fluconazole Read all of this leaflet carefully before you start taking this medicine because it contains
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
PFIZER Package leaflet: Information for the patient …
www.medicines.org.ukPage 1 of 20 PFIZER Package leaflet: Information for the patient Depo-Provera® 150 mg/ml Sterile Suspension for Injection Medroxyprogesterone acetate Please read all of this leaflet carefully before you start using this medicine because it
SAYANA PRESS 104 mg/0.65 ml suspension for …
www.medicines.org.ukPage 1 of 15 Package leaflet: Information for the user SAYANA PRESS® 104 mg/0.65 ml suspension for injection medroxyprogesterone acetate Single-dose container ...
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1. Package Leaflet 1 PACKAGE LEAFLET: INFORMATION FOR THE USER CALCEOS 500mg/400IU CHEWABLE TABLETS …
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1 Package Leaflet 1 Package leaflet: Information for the patient Laxido Orange, powder for oral solution. Read all of this leaflet carefully before you start taking this medicine because it contains
Package leaflet: Information for the user Clexane …
www.medicines.org.uk1 Package leaflet: Information for the user. Clexane® Syringes 2,000 IU (20 mg)/0.2 ml solution for injection in pre-filled syringes . Clexane® Syringes 4,000 IU (40 mg)/0.4 ml solution for injection in pre-filled syringes
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER Bisoprolol 2.5 mg Film-coated Tablet Bisoprolol 5 mg Film-coated Tablet Bisoprolol 10 mg Film-coated Tablet
Package leaflet: Information for the user - Medicines
www.medicines.org.ukPage 1 of 8 v019_0 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack.
Package leaflet: Information for the user …
www.medicines.org.ukRead all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet.
small pharma code may appear on the front / back …
www.medicines.org.ukKeep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and carton after EXP.
Patient Information Leaflet - Medicines
www.medicines.org.ukPage 2 of 10 Patient Information Leaflet Salazopyrin® EN-tabs 500 mg enteric-coated tablets sulfasalazine In this leaflet: 1. What Salazopyrin EN …
Related documents
HIGHLIGHTS OF PRESCRIBING INFORMATION Age group …
www.merck.comFULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 1.1 Complicated Skin and Skin Structure Infections(cSSSI) 1.2 Staphylococcus aureus Bloodstream Infections
CYANIDE ANTIDOTE PACKAGE For the Treatment of …
www.abopharmaceuticals.comPrepeared By: Zylex Pharmaceuticals Compliance and Regulatory Division The use of the above treatment information is designed to assist governmental agencies in ascertaining the regulatory relevance for specific industry regulations
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER Flucloxacillin 250mg Capsules BP Flucloxacillin 500mg Capsules BP (flucloxacillin sodium) Read all of this leaflet carefully before you start taking this medicine.
SODIUM BICARBONATE INJ., 8.4% USP NEUTRALIZING …
onpharma.comCopyright © 2017 Onpharma Company. All Rights Reserved (11/2011) LS013-D SODIUM BICARBONATE INJ., 8.4% USP NEUTRALIZING ADDITIVE SOLUTION
HYDRODIURIL (HYDROCHLOROTHIAZIDE)
www.hypertensionmeds.com7897450 TABLETS HYDRODIURIL® (HYDROCHLOROTHIAZIDE) DESCRIPTION HydroDIURIL* (Hydrochlorothiazide) is a diuretic and antihypertensive. It is the 3,4-dihydro derivative of
DESYREL - mentalmeds.org
www.mentalmeds.orgDESYREL® (Trazodone Hydrochloride) DESCRIPTION DESYREL (trazodone hydrochloride) is an antidepressant chemically unrelated to tricyclic, tetracyclic, or other known antidepressant agents.
HIGHLIGHTS OF PRESCRIBING INFORMATION See Full …
www.vabomere.com2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1. Complicated Urinary Tract Infections (cUTI), including Pyelonephritis VABOMERE™ is indicated for the treatment of patients 18 years of age and older with